Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East

Código QR

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East

Sulaiman Alkhadhari,1 Nasser Al Zain,2 Tarek Darwish,3 Suhail Khan,4 Tarek Okasha,5 Hisham Ramy,5 Talaat Matar Tadros6 1Kuwait Center for Mental Health, Safat, Kuwait; 2Al Amal Complex for Mental Health Hospital, Dammam, Saudi Arabia; 3Behavioural Science Pavilion, Sheikh Khalifa Medical City, Abu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alkhadhari S, Al Zain N, Darwish T, Khan S, Okasha T, Ramy H, Tadros TM
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/25c9a25d46c1440e80872cf86ad63980
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
por: Pawelczyk T, et al.
Publicado: (2015)

Iminodibenzyl class antipsychotics for schizophrenia: a systematic review and meta-analysis of carpipramine, clocapramine, and mosapramine
por: Kishi T, et al.
Publicado: (2014)

Social cognitive and neurocognitive deficits in inpatients with unilateral thalamic lesions — pilot study
por: Wilkos E, et al.
Publicado: (2015)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka M, et al.
Publicado: (2015)

Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder
por: Azekawa T, et al.
Publicado: (2011)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
por: Yang X, et al.
Publicado: (2015)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
por: Montemagni C, et al.
Publicado: (2016)

The clinical psychologist and the management of inpatient pain: a small case series
por: Childs SR, et al.
Publicado: (2014)

Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
por: Fang X, et al.
Publicado: (2019)

Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test
por: Nakamura M, et al.
Publicado: (2014)

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first- episode or multi-episode schizophrenia
por: Washida K, et al.
Publicado: (2013)

The role of family therapy in the management of schizophrenia: challenges and solutions
por: Caqueo-Urízar A, et al.
Publicado: (2015)

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics
por: Adam UU, et al.
Publicado: (2014)

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample
por: Goetz M, et al.
Publicado: (2015)

Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study
por: Gutiérrez-Fernández J, et al.
Publicado: (2015)

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
por: Yin J, et al.
Publicado: (2019)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
por: Karthikeyan R, et al.
Publicado: (2014)

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust J, et al.
Publicado: (2015)

Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders, and negative symptoms
por: Urban-Kowalczyk M, et al.
Publicado: (2015)

Schizophrenia Treatment with Second-Generation Antipsychotics: A Multi-Country Comparison of the Costs of Cardiovascular and Metabolic Adverse Events and Weight Gain
por: Kearns B, et al.
Publicado: (2021)

Zonisamide in the management of epilepsy in the elderly
por: Romigi A, et al.
Publicado: (2015)

Predictors of improved functional outcome in elderly inpatients after rehabilitation: a retrospective study
por: Naruishi K, et al.
Publicado: (2014)

The severe complication of Stevens–Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report
por: Wu MK, et al.
Publicado: (2015)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

Cervical Ossification of Ligamentum Flavum: Elaborating an Underappreciated but Occasional Contributor to Myeloradiculopathy in Aging Population Based on Synthesis of Individual Participant Data
por: Zhang B, et al.
Publicado: (2021)

Catatonia in Down syndrome; a treatable cause of regression
por: Ghaziuddin N, et al.
Publicado: (2015)

Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia
por: Liang Y, et al.
Publicado: (2016)

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia
por: Fujiki R, et al.
Publicado: (2014)

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
por: Babij R, et al.
Publicado: (2015)

Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
por: Chen Y, et al.
Publicado: (2020)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka M, et al.
Publicado: (2015)

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
por: Cai SL, et al.
Publicado: (2015)

Antipsychotics and risk of natural death in patients with schizophrenia
por: Chen Y, et al.
Publicado: (2019)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Xinhua&nbsp;S Ren, et al.
Publicado: (2009)

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
por: Iancu I, et al.
Publicado: (2015)

Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes
por: Qu M, et al.
Publicado: (2015)

The Relationship between the Second-Generation Antipsychotics Efficacy and the Traditional Chinese Medicine Body Constitutions in Patients with Schizophrenia
por: Tzu-Pei Yeh, et al.
Publicado: (2021)

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang HR, et al.
Publicado: (2015)

Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study
por: Hsu YC, et al.
Publicado: (2015)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Hong Liu-Seifert, et al.
Publicado: (2009)